Trial Profile
Ticagrelor in Methotrexate-Resistant Rheumatoid Arthritis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Oct 2021
Price :
$35
*
At a glance
- Drugs Ticagrelor (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms TIMERA
- 05 Jul 2019 Status changed from recruiting to completed.
- 25 Jan 2019 Planned End Date changed from 15 Nov 2018 to 15 Jun 2019.
- 25 Jan 2019 Planned primary completion date changed from 15 Jul 2018 to 15 Jun 2019.